Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 369,628,000
  • Market Capitalization, $K 369,628
  • Shares Outstanding, K 2,150
  • 60-Month Beta 0.92
Trade IHE with:
  • Price/Earnings ttm 25.41
  • Annual Dividend & Yield 2.12 (1.24%)
  • Most Recent Dividend 0.709 on 09/23/20
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.93 +8.29%
on 10/30/20
175.67 -2.65%
on 11/09/20
+2.91 (+1.73%)
since 10/23/20
3-Month
157.93 +8.29%
on 10/30/20
175.67 -2.65%
on 11/09/20
+5.83 (+3.53%)
since 08/21/20
52-Week
115.53 +48.03%
on 03/23/20
175.67 -2.65%
on 11/09/20
+22.32 (+15.01%)
since 11/22/19

Most Recent Stories

More News
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 64.66 (-0.26%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
XPH : 47.96 (-0.39%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 64.66 (-0.26%)
NVO : 66.55 (-1.26%)
AZN : 53.71 (-1.81%)
BMY : 62.34 (+0.68%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 47.96 (-0.39%)
RPRX : 40.20 (-0.42%)
HZNP : 70.05 (-0.14%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
MYOK : 224.91 (+0.05%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 64.66 (-0.26%)
NVO : 66.55 (-1.26%)
AZN : 53.71 (-1.81%)
BMY : 62.34 (+0.68%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

PPH : 64.66 (-0.26%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
XPH : 47.96 (-0.39%)
FTXH : 25.00 (-0.56%)
ETFs to Shine on Lilly's U.S. Deal for Coronavirus Antibody

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 64.66 (-0.26%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
XPH : 47.96 (-0.39%)
Healthcare ETFs: Winners & Losers in the Light of U.S. Election

The coronavirus vaccine development effort has put the spotlight on the U.S. healthcare sector in recent months.

IHI : 310.13 (-0.64%)
IHF : 224.43 (+0.30%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
XHE : 105.68 (+0.63%)
GNOM : 20.33 (unch)
CNBS : 16.00 (+4.17%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 64.66 (-0.26%)
NVO : 66.55 (-1.26%)
AZN : 53.71 (-1.81%)
BMY : 62.34 (+0.68%)
PJP : 67.09 (-0.63%)
IHE : 171.02 (-0.55%)
J&J Pauses Coronavirus Vaccine Trial: ETFs That May Take a Hit

Johnson & Johnson's pausing of dosing in all clinical studies on its coronavirus vaccine candidate has increased uncertainty surrounding the coronavirus vaccine development.

XLV : 109.09 (+0.53%)
VHT : 213.00 (+0.31%)
IYH : 234.22 (-0.14%)
IHE : 171.02 (-0.55%)
IEIH : 30.92 (+0.06%)
JNJ Beats Q3 Earnings, Lifts Outlook: Healthcare ETFs in Focus

Despite solid results and an upbeat view, shares of JNJ dropped as the company halted its final-phase of clinical trials for its COVID-19 vaccine candidate.

JNJ : 144.40 (+0.37%)
XLV : 109.09 (+0.53%)
VHT : 213.00 (+0.31%)
IYH : 234.22 (-0.14%)
IHE : 171.02 (-0.55%)
IEIH : 30.92 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 173.19
1st Resistance Point 172.11
Last Price 171.02
1st Support Level 170.17
2nd Support Level 169.31

See More

52-Week High 175.67
Last Price 171.02
Fibonacci 61.8% 152.70
Fibonacci 50% 145.60
Fibonacci 38.2% 138.50
52-Week Low 115.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar